I'm glad they are "laser focused" on CD12 but I still believe long haulers are going to be are bread and butter. They're suffering, just not enough to require hospitalization, which means they are being over looked in the majority of ongoing trials. I hope they iron out which data points to concentrate on and do it in a hurry. There are numerous articles about "help groups" consisting of thousands of long hauler members. With our safety profile, 100 patients would be filled quicker than my tapped IPA in 4 hours. Help one and word will spread like wild fire- sorry California!